Solid Biosciences Inc.
SLDB
$9.54
-$0.39-3.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.42% | -13.96% | -8.76% | -15.95% | -0.50% |
| Total Depreciation and Amortization | -1.01% | -15.42% | 24.20% | -2.59% | -5.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.37% | -24.50% | 89.57% | 12.65% | -19.32% |
| Change in Net Operating Assets | -270.82% | 117.41% | -284.71% | 382.51% | -241.61% |
| Cash from Operations | -11.34% | 11.81% | -60.00% | 10.53% | -17.46% |
| Capital Expenditure | 9.09% | 70.80% | -564.71% | 77.45% | -199.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -397.04% | -5.41% | 205.10% | -39.66% | -18.36% |
| Cash from Investing | -398.47% | -4.80% | 203.85% | -38.31% | -19.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 16.46% | -71.13% | -5.19% |
| Issuance of Common Stock | -80.46% | 4,612.25% | 276.74% | 602.48% | -99.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.15% | -- | -- | 100.00% | -8,205.00% |
| Cash from Financing | -79.72% | 4,547.62% | 337.33% | 173.45% | -100.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -158.21% | 17,020.96% | 98.20% | -8.12% | -155.01% |